Kamyab Javanmardi
-
- SARS-CoV-2 and COVID-19 Research 3
-
- CRISPR and Genetic Engineering 7
- RNA and protein synthesis mechanisms 5
-
- Bacterial Genetics and Biotechnology 2
- Genetics and Neurodevelopmental Disorders 2
-
- Lanthanide and Transition Metal Complexes 2
-
- Electron Spin Resonance Studies 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Andrew D. EllingtonIlya J. FinkelsteinRoss ThyerSimon d’OelsnitzHal S. AlperWantae KimYan ZhangKevin J. Forsberg
- Journals
- Nucleic Acids Research (1 paper)Angewandte Chemie International Edition (1 paper)Nature Biotechnology (1 paper)
- Partner nations
- United StatesHungarySerbia
In The Last Decade
Kamyab Javanmardi
13 papers receiving 372 citations
Peers
Comparison fields: 5 of 72
- Business and International Management 19
- Infectious Diseases 76
- Molecular Biology 262
- Genetics 101
- Biotechnology 20
Countries citing papers authored by Kamyab Javanmardi
This map shows the geographic impact of Kamyab Javanmardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamyab Javanmardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamyab Javanmardi more than expected).
Fields of papers citing papers by Kamyab Javanmardi
This network shows the impact of papers produced by Kamyab Javanmardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamyab Javanmardi. The network helps show where Kamyab Javanmardi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kamyab Javanmardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 61 | |
| 6 | 2022 | 23 | |
| 7 | 2021 | 32 | |
| 8 | 2021 | 36 | |
| 9 | 2021 | 64 | |
| 10 | 2021 | 6 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 57 | |
| 14 | 2019 | 57 | |
| 15 | 2018 | 11 |
About Kamyab Javanmardi
Kamyab Javanmardi is a scholar working on Biophysics, Genetics and Molecular Biology, having authored 15 papers that have together received 376 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), RNA and protein synthesis mechanisms (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Lanthanide and Transition Metal Complexes (2 papers), Bacterial Genetics and Biotechnology (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Electron Spin Resonance Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Business and International Management (19 citations), Infectious Diseases (76 citations) and Molecular Biology (262 citations). Kamyab Javanmardi has collaborated with scholars based in United States, Hungary and Serbia. Frequent co-authors include Andrew D. Ellington, Ilya J. Finkelstein, Ross Thyer, Simon d’Oelsnitz, Hal S. Alper, Wantae Kim, Yan Zhang, Kevin J. Forsberg, Danica T. Schmidtke and Brett K. Kaiser. Their work appears in journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.